AS1810722 is an orally effective STAT6 inhibitor with an IC50 of 1.9 nM. AS1810722 shows good CYP3A4 inhibition and is a thickened bicyclic pyrimidine derivative with potential for use in allergic disease studies, such as asthma and atopic diseases.
Molekulargewicht:
477.51
Reinheit:
>98.0%
CAS Nummer:
[909561-15-5]
Formel:
C25H25F2N7O
Target-Kategorie:
STAT
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten